In AD, the α2A-AR has been implicated in amyloidogenesis and the inhibition of α2-Ars; mesedin has been proven beneficial in cell models [12] and a mouse model of AD [33,49], while levels of α2-AR have been found to be reduced in AD patients [50]. Here, ADORA2A is linked to Alzheimer disease.